RS

Raunak Shrivastava

Director Director DIN 06462109
DIN 06462109 First appointment Mar 2013 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2013
Shareholding value Locked Premium profile

About Raunak Shrivastava

Raunak Shrivastava has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06462109
Primary Designation Director
First Appointment 04 Mar 2013
Oldest Company Age 13 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Macon Medicines Private Limited U24232MP2013PTC030189
Director 04 Mar 2013 2013 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Macon Medicines Private Limited
Premium access

Shareholding and investment profile for Raunak Shrivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raunak Shrivastava

Raunak Shrivastava has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Raunak Shrivastava is associated with 0 companies as Director.

Raunak Shrivastava has expertise in General Business.

Raunak Shrivastava has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available